Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1  by Petronczki, Mark et al.
Developmental Cell
ReviewPolo on the Rise—from Mitotic Entry
to Cytokinesis with Plk1
Mark Petronczki,1,3,* Pe´ter Le´na´rt,2,3,4 and Jan-Michael Peters2,*
1Cell Division and Aneuploidy Laboratory, Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms,
Hertfordshire, EN6 3LD, United Kingdom
2Research Institute of Molecular Pathology (IMP), A-1030 Vienna, Austria
3These two authors contributed equally to this work.
4Present address: Gene Expression Unit, European Molecular Biology Laboratory, D-69117 Heidelberg, Germany.
*Correspondence: mark.petronczki@cancer.org.uk (M.P.), jan-michael.peters@imp.ac.at (J.-M.P.)
DOI 10.1016/j.devcel.2008.04.014
Polo-like kinase 1 (Plk1) is a key regulator of cell division in eukaryotic cells. New techniques, including the
application of small-molecule inhibitors, have greatly expanded our knowledge of the functions, targets,
and regulation of this key mitotic enzyme. In this review, we focus on how Plk1 is recruited to centrosomes,
kinetochores, and the spindle midzone and what the specific tasks of Plk1 at these distinct subcellular struc-
tures might be. In particular, we highlight new work on the role of Plk1 in cytokinesis in human cells. Finally,
we describe how better understanding of Plk1 functions allows critical evaluation of Plk1 as a potential drug
target for cancer therapy.The gene for the serine/threonine kinase known as Polo in
Drosophila, Plk1 (Polo-like kinase 1) in vertebrates (often also re-
ferred to as Plx1 in Xenopus), and Cdc5 in budding yeast was
first identified in genetic yeast and Drosophila screens for mu-
tants defective in cell division (Hartwell et al., 1973; Sunkel and
Glover, 1988). The cloning of the Drosophila polo gene subse-
quently identified its product as a protein kinase (Llamazares
et al., 1991). Since this early pioneering work, Polo and its ortho-
logs have been recognized not only as key regulators of mitosis
but also cytokinesis (Barr et al., 2004; Carmena et al., 1998). Hu-
man Plk1 belongs to a family of four related kinases with largely
nonoverlapping functions (van de Weerdt and Medema, 2006).
This review focuses on Plk1 (Figure 1A), the most prominent reg-
ulator of cell division within the Plk family.
In yeasts and animal cells, Polo kinase is no less important for
the cell division cycle than cyclin-dependent kinases (Cdks).
Without Polo, animal cells fail to assemble a proper bipolar spin-
dle and instead arrange their mitotic chromosomes in a circular
fashion around a monopolar spindle (thus the name Polo; Sunkel
and Glover, 1988) (Figure 2A). In Xenopus and humans, Plk1 is
also required for proper timing of mitotic entry (Qian et al.,
1998; Sumara et al., 2004), and in yeast, Cdc5 is essential for
exit frommitosis and cytokinesis (Stegmeier et al., 2002; Yoshida
et al., 2006). In addition, Polo orthologs have been implicated in
several other mitotic processes, such as dissociation of cohesin
complexes from chromosome arms (Losada et al., 2002; Sumara
et al., 2002), phosphorylation of the anaphase-promoting com-
plex/cyclosome (APC/C) (Golan et al., 2002; Kraft et al., 2003),
and degradation of the APC/C inhibitor Emi1 (Hansen et al.,
2004; Lenart et al., 2007;Moshe et al., 2004). Inmammalian cells,
amore detailed and comprehensive investigation of themany im-
portant functions of Plk1 has only become possible recently
through the development and application of new research tools
and technologies. These include methods for inactivation of
Plk1 by RNA interference (RNAi), specific small-molecule inhibi-
tors (reviewed in Taylor and Peters, 2008), and the generation646 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.of geneticallymodified alleles (Burkard et al., 2007). Furthermore,
the identification of Plk1 substrates and interaction partners has
been facilitated by peptide and protein binding studies andmass
spectrometry (e.g., Baumannet al., 2007; Lowery et al., 2007) and
the solution of Plk1 structures at atomic level by X-ray crystallog-
raphy (Kothe et al., 2007a, 2007b). The development of potent
and specific small-molecule Plk1 inhibitors has for the first time
allowed acute inactivation of Plk1 after the metaphase to ana-
phase transition to probe Plk1’s late mitotic functions, which
have hitherto been eclipsed by its essential earlier functions.
These experiments have uncovered novel roles for Plk1 in
initiating cleavage furrow ingression and spindle elongation in hu-
man anaphase cells (Brennan et al., 2007; Burkard et al., 2007;
Petronczki et al., 2007; Santamaria et al., 2007). Furthermore,
these novel chemical tools have also enabled studies in which
the potential suitability of Plk1 as a target for antiproliferative
cancer therapy can be evaluated (Steegmaier et al., 2007; Streb-
hardtandUllrich,2006). In this review,wediscuss theseadvances
in basic and applied Plk1 biology and point to themany important
open questions that remain to be addressed in the future.
Recruitment of Plk1 to Different Subcellular Sites
Although Plk1 can also be regulated by phosphorylation (Barr
et al., 2004; Yamashiro et al., 2008, this issue) and protein deg-
radation (Lindon and Pines, 2004), the most striking feature of
Plk1 is its changing localization to various subcellular structures
during mitotic progression. Plk1 first associates with centro-
somes in prophase, then also becomes enriched at kinetochores
in prometaphase and metaphase, is afterwards recruited to the
central spindle in anaphase, and finally accumulates in the mid-
body during telophase (Figure 1B). How is Plk1 recruited to these
subcellular structures and what is the functional relevance of
these localizations?
A first answer to these questions emerged from studies of Elia
and colleagues (Elia et al., 2003a, 2003b) who discovered that
the previously recognized conserved sequence elements in the
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ReviewFigure 1. Localization and Function of Plk1 throughout Mitosis in Human Cells
(A) Domain structure of human Plk1 (numbers delimiting domains correspond to amino acid positions).
(B) Localization of Plk1 (green) throughout mitosis in human cells. Functions attributed to Plk1 are indicated below the corresponding mitotic stages (NEBD,
nuclear envelope breakdown). Plk1 substrates and interacting proteins are listed below the dashed line in boxes corresponding to Plk1 functions. This listing
of Plk1 functions, targets, and interacting factors is not exhaustive and focuses on topics and proteins discussed in this review.C-terminal portion of Plk1 function as a phosphopeptide binding
domain, referred to as the Polo-box domain (PBD) (Elia et al.,
2003a) (Figure 1A). This discovery suggested that the PBD
might have an important role in directing Plk1 to substrates.
Thereby, the PBD might contribute to substrate specificity and
possibly subcellular localization of Plk1. In addition, the obser-
vation that the PBD preferentially binds to phosphorylated
peptides implied that another kinase first has to ‘‘prime’’ the
site before PBD binding. This suggested a mechanism that
can efficiently target Plk1 spatially and temporally—timed rela-
tive to previous phosphorylation events (Lowery et al., 2004,
2005). These findings also provided an explanation for earlier
studies indicating that the PBD is necessary and sufficient for
proper localization of Plk1 to centrosomes, kinetochores, and
the midbody, implying that Plk1 is recruited to different subcel-
lular sites via direct physical interaction with phosphorylated
proteins (Lee et al., 1998; Seong et al., 2002). Many phospho-
proteins with which Plk1 can interact may themselves be
substrates of Plk1, but it is also conceivable that phosphory-
lated docking proteins exist which help to increase local Plk1
concentrations without being direct targets of Plk1 phosphory-
lation. Using the PBD as bait, several hundred candidate inter-
action partners of Plk1 have been identified that bind to the PBD
in a phosphorylation-dependent manner (Lowery et al., 2007).
Here we discuss those interactors that have been characterized
in more detail and highlight the new principles of regulation that
emerge from these studies.
Functions of Plk1 at Centrosomes
The original identification of Drosophila Polo as a gene whose
mutation causes defective centrosomes andmonopolar spindles
(Sunkel and Glover, 1988) and the localization of Plk1 at centro-somes (Golsteyn et al., 1995) suggested that this kinase has im-
portant functions at centrosomes and thus in the assembly
of bipolar spindles. One of these functions is the recruitment of
g-tubulin complexes to centrosomes during prophase (Lane
and Nigg, 1996). This process, referred to as centrosome matu-
ration, is essential for microtubule nucleation from mitotic cen-
trosomes. The mechanism whereby Plk1 facilitates centrosome
maturation is not fully understood, but it has been postulated that
Plk1 can contribute to centrosome maturation by phosphorylat-
ing the centrosomal protein Nlp. This modification leads to Nlp
dissociation from centrosomes during mitosis and may facilitate
recruitment of g-tubulin complexes (Casenghi et al., 2003, 2005).
In addition to Nlp, a recently identified Plk1 substrate named
Kizuna has also been shown to be required for formation of
functional mitotic centrosomes (Oshimori et al., 2006). If Kizuna
is depleted or cannot be phosphorylated by Plk1, centrosomes
loose their mechanical stability and therefore are fragmented
by the forces generated by spindle microtubules (Oshimori
et al., 2006). Drosophila Polo has also been shown to phosphor-
ylate the conserved microtubule minus end-binding protein Asp
to facilitate nucleation of microtubules by mitotic centrosomes
(do Carmo Avides et al., 2001). Inactivation of Plk1 by addition
of small-molecule inhibitors before and after the assembly bipo-
lar spindles has revealed that Plk1 is not only required for the
establishment of a bipolar spindle and functional centrosomes,
but also for their maintenance (D’Avino et al., 2006; Lenart
et al., 2007; McInnes et al., 2006; Peters et al., 2006; Santamaria
et al., 2007). However, centrosomes function normally even if the
centrosomal localization of Plk1 is disrupted by overexpression
of the PBD domain or by expressing a version of Plk1 without
PBD (Hanisch et al., 2006). One explanation for this observation
is that Plk1’s centrosomal substrates may not be stably boundDevelopmental Cell 14, May 2008 ª2008 Elsevier Inc. 647
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pool that could be sufficient to mediate the phosphorylation
reaction. Alternatively, cytoplasmic Plk1 might be capable to
modify stably bound centrosomal factors.
Although Plk1’s PBD docking interactions appear to be dis-
pensable for centrosome maturation, centrosomal recruitment
of Plk1 might play an important role in controlling the timing of
mitotic entry. Elia and colleagues chose the protein phosphatase
Cdc25C for the initial testing of their hypothesis that Plk1 prefer-
entially recognizes ‘‘primed’’ substrates because Cdc25C had
been shown to be activated following its phosphorylation by
Plk1 in Xenopus oocytes (Kumagai and Dunphy, 1996; Qian
et al., 1998). Elia et al. showed that the PBD is required for
efficient binding of Plk1 to Cdc25C and that this interaction is
specific to the mitotic form of Cdc25C that has been prephos-
phorylated by Cdk1 (Elia et al., 2003a). Because Cdc25C is
required for Cdk1-cyclin B1 activation, which is thought to occur
during prophase at centrosomes (Jackman et al., 2003), Cdc25C
may be an important centrosomal substrate of Plk1. Cyclin B1 it-
self is also phosphorylated by Plk1 in prophase at centrosomes,
and this modification is thought to contribute to Cdk1-cyclin B1
activation as well (Jackman et al., 2003; Toyoshima-Morimoto
et al., 2001). The recruitment of Plk1 to centrosomes may thus
promote mitotic entry, a function likely conserved from yeast
(Mulvihill et al., 1999) to vertebrates. Several observations
indicate, however, that neither Plk1 nor its accumulation at
centrosomes is essential for entry into mitosis. If Plk1 has been
mislocalized (Hanisch et al., 2006), and even if Plk1 has been
pharmacologically inhibited (Lenart et al., 2007), mammalian cul-
tured cells can still enter mitosis. These cells are delayed for
hours in late prophase (Lenart et al., 2007), at the time when
Cdk1 activation is believed to occur at centrosomes, but eventu-
ally nuclear envelope breakdown occurs in these cells. Activa-
tion of Cdk1 may therefore also be possible in the absence of
Plk1, although after a long delay. Whereas Plk1 is not essential
for mitotic entry in unperturbed divisions, recovery from a DNA
damage checkpoint-induced arrest at the G2/M boundary and
restart of the cell cycle requires Plk1 activity in both yeast and
human cells (Toczyski et al., 1997; van Vugt et al., 2004a).
Figure 2. Close-Up Look at the Monopolar
Prometaphase-Arrest Caused by Plk1
Inhibition
(A) Kinetochore, a-tubulin, and g-tubulin staining
in a control metaphase cell (left) and a Plk1 inhib-
itor-treated cell arrested at prometaphase (right)
(images reproduced from Lenart et al., 2007).
(B) Thin section electron micrographs of control
and Plk1 inhibitor-treated cells showing kineto-
chores (K) with attached K-fibers (Kf) (left) and
defective attachment (right) (images reproduced
from Lenart et al., 2007).
A third group of proteins that are en-
riched at centrosomes and known to be
substrates of Plk1 are the APC/C and its
inhibitor Emi1. During S and G2 phase,
Emi1 helps to inhibit the ubiquitin ligase
activity of the APC/C, which would other-
wise precociously target mitotic cyclins
and other proteins for destruction by the 26S proteasome. In
late prophase, Plk1 phosphorylates Emi1 and thereby allows
its recognition by the ubquitin ligase SCFbTrcp1, which medi-
ates degradation of Emi1 (Hansen et al., 2004; Moshe et al.,
2004). Presumably around the same time, Plk1 contributes to
phosphorylation of the APC/C (Golan et al., 2002; Kraft et al.,
2003), which is one of several prerequisites for APC/C’s activa-
tion in mitosis. It is unknown where in the cell these phosphory-
lation reactions occur, but APC/C, Emi1, and Plk1 are all present
on centrosomes, suggesting that some of the reactions may oc-
cur at this site. APC/C phosphorylation and activation can also
occur in the absence of Plk1 activity (Kraft et al., 2003; Lenart
et al., 2007), presumably at the hands of Cdk1, but under these
conditions phosphorylated APC/C is no longer enriched at cen-
trosomes (Kraft et al., 2003). Perhaps interactions between
phosphorylated APC/C subunits and the PBD of Plk1 contribute
directly to the recruitment of APC/C to centrosomes.
New work has revealed that Plk1 activity at centrosomes and
possibly other structures does not remain unchecked but is
antagonized by protein phosphatase 1C (PP1C) bound to a reg-
ulatory subunit called myosin phosphatase targeting subunit1
(MYPT1) (Yamashiro et al., 2008). Depletion of MYPT1 restores
centrosome function and mitotic progression in cells with re-
duced Plk1 levels. In mitosis, PP1C/MYPT1 is primed by Cdk1
phosphorylation and then associates with the PBD of Plk1. Sub-
sequently, PP1C/MYPT1 might directly inhibit Plk1 by dephos-
phorylating Plk1 at T210, an activating site. It remains to be
seen how critical the fine-tuned balance of the two opposing
enzymatic activities of Plk1 and PP1C/MYPT1 is for different
aspects of cell division.
Functions of Plk1 at Kinetochores
The possibility that Plk1 may also have functions at kineto-
chores, the chromosomal structures to which spindle microtu-
bules attach, was first raised by the observation that Plk1
accumulates at these sites in prometaphase (Arnaud et al.,
1998) (Figure 1B). Subsequent work revealed that inactivation
of Plk1 reduces the number of microtubules that attach to kinet-
ochores (‘‘K-fibers’’; Sumara et al., 2004) and showed directly648 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.
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microtubule-kinetochore attachments (Lenart et al., 2007)
(Figure 2B). Hanisch et al. observed that PBD overexpression
or mislocalization of Plk1 also causes chromosome congression
errors that are indicative of kinetochore defects (Hanisch et al.,
2006). This suggested that Plk1 localization at kinetochores is
essential for Plk1 to perform its functions at this site. Second,
since centrosome maturation is normal in these cells (see
above), these observations indicate that the microtubule-kineto-
chore attachment defects that are seen in Plk1-deficient cells are
not simply an indirect consequence of centrosome defects.
Recent reports have described several kinetochore proteins
with which Plk1 can interact and which may contribute to the
recruitment of Plk1 to kinetochores. Plk1 is first expressed in
S-phase (Hamanaka et al., 1994; Holtrich et al., 1994) and can
be detected in G2-phase at centromeres (Kang et al., 2006)
(Figure 1B), the chromosomal sites at which kinetochores as-
semble in mitosis. Kang et al. reported that the recruitment of
Plk1 to this site depends on a centromeric protein known as
KLIP1/MFL1IP in mammalian cells and as CENP-50 in chickens,
now renamed Polo-box interacting protein 1 (PBIP1; Kang et al.,
2006). Interestingly, phosphorylation of PBIP1 by Plk1 creates
a binding site for the PBD via a ‘‘self-priming’’ mechanism, and
thereby, Plk1 docks itself to centromeres (Lee et al., 2008).
However, Plk1 phosphorylation also targets PBIP1 for degra-
dation in early mitosis (Kang et al., 2006), whereas Plk1 persists
at kinetochores until telophase (Figure 1B). Thus, other interac-
tion partners must contribute to Plk1 localization at kinetochores
during mitosis. One of these interaction partners is Bub1, a pro-
tein kinase that is recognized by the PBD of Plk1 once Bub1 has
been phosphorylated by Cdk1 (Qi et al., 2006). A similar mecha-
nism has been identified for INCENP, a subunit of the chromo-
somal passenger complex, and MCAK (Goto et al., 2006; Ro-
sasco-Nitcher et al., 2008). Similarly to Bub1, phosphorylation
of INCENP by Cdk1 creates a binding site for the PBD and
thus allows interactions with Plk1, which may facilitate accumu-
lation of Plk1 at kinetochores (Goto et al., 2006). Finally, the outer
kinetochore protein NudC is also a substrate of Plk1 that is
needed for recruitment of Plk1 to kinetochores (Nishino et al.,
2006). Potentially, all of these proteins could contribute to Plk1
localization as direct binding partners, but presently it is difficult
to exclude that depletion of these proteins also affects Plk1 lo-
calization indirectly, e.g., by altering kinetochore structure. Fur-
thermore, Plk1 activity is also required for accumulation of the
enzyme at kinetochores (Lenart et al., 2007; Santamaria et al.,
2007), which indicates that self-priming mechanisms are impor-
tant throughout mitosis.
Once recruited to kinetochores, what are the key substrates
and functions of Plk1 at this site? One hint to answer this ques-
tion comes from the observation that the levels of Plk1 are
particularly high on the kinetochores of those chromosomes
that have not yet been attached to both poles of the mitotic spin-
dle and are not under tension (Ahonen et al., 2005; Lenart et al.,
2007) (Figure 1B). These kinetochores activate the spindle
assembly checkpoint, a mechanism that inhibits the APC/C
and thereby delays anaphase until all chromosomes have been
attached to both spindle poles. Thus, the finding that Plk1 levels
are particularly high on unattached kinetochores implies that
Plk1 may have important roles either in promoting microtubule-kinetochore attachments or in regulation of the spindle assembly
checkpoint.
Plk1 function is indeed connected to the spindle assembly
checkpoint through several substrates. Plk1 phosphorylates
BubR1 and, as already mentioned, the related enzyme Bub1,
protein kinases that are both required for the spindle assembly
checkpoint. Plk1 also phosphorylates a putative DNA helicase,
called PICH, which is located at centromeres and is also needed
for spindle assembly checkpoint function (Baumann et al., 2007).
Finally, Plk1 is required for generation of the well-studied phos-
phoepitope, 3F3/2, which is specifically generated at kineto-
chores that are not under tension (Ahonen et al., 2005; Wong
and Fang, 2005). A recent study suggests that the 3F3/2 epitope
resides on BubR1 and may be required for spindle assembly
checkpoint arrest in Xenopus extracts (Wong and Fang, 2007).
However, none of these phosphorylation reactions appears to
be essential for the spindle assembly checkpoint in somatic
cells, because inactivation of Plk1 by either RNAi or pharmaco-
logic inhibition causes a prolonged arrest of cells in prometa-
phase which is due to activation of the spindle assembly
checkpoint (Lenart et al., 2007; McInnes et al., 2006; Peters
et al., 2006; Santamaria et al., 2007; Steegmaier et al., 2007;
Sumara et al., 2004; van Vugt et al., 2004b) (Figure 2A). In these
cells, the checkpoint proteins Mad2, BubR1, and Bub1 brightly
label almost all kinetochores indicative of checkpoint activation
(Lenart et al., 2007; Santamaria et al., 2007; Sumara et al.,
2004; van Vugt et al., 2004b). Furthermore, the arrest in prome-
taphase is abolished if proteins of the spindle assembly
checkpoint are experimentally inactivated, confirming that
Plk1-deficient cells arrest in mitosis due to activation of the spin-
dle assembly checkpoint (Lenart et al., 2007; Santamaria et al.,
2007; Sumara et al., 2004; van Vugt et al., 2004b).
It is therefore more plausible to think that the role of Plk1 at
unattached kinetochores may be to promote the formation of
stable microtubule-kinetochore attachments (Figure 2). This
notion is directly supported by the electron microscopic obser-
vation that normal end-on attachments of microtubules to kinet-
ochores cannot be formed if Plk1 is inhibited (Lenart et al., 2007).
However, somemore lateral contacts betweenmicrotubules and
kinetochores can be seen after Plk1 inhibition (Lenart et al.,
2007). Such lateral attachments are normally formed transiently
before end-on attachments are generated (Kapoor et al., 2006).
It will therefore be interesting to address if Plk1 has a direct role in
the conversion of lateral to end-on attachments of microtubules.
One Plk1 substrate whose phosphorylation may be important
for microtubule-kinetochore attachments is BubR1 (Elowe et al.,
2007; Lenart et al., 2007; Matsumura et al., 2007). BubR1 is
required both for the spindle assembly checkpoint (Meraldi
et al., 2004) and for microtubule-kinetochore attachments
(Lampson and Kapoor, 2005), but only the latter function de-
pends on phosphorylation of BubR1 by Plk1 (Elowe et al.,
2007). Interestingly BubR1 phopshorylation by Plk1 is particulary
high at kinetochores that are not under tension (Elowe et al.,
2007), implying that Plk1 might create a modified form of
BubR1, which is needed for the formation of microtubule-kinet-
ochore attachments. It will be important to understand how the
absence of tension activates BubR1 phosphorylation by Plk1
and likewise how the active form of BubR1 promotes microtu-
bule-kinetochore attachments.Developmental Cell 14, May 2008 ª2008 Elsevier Inc. 649
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the localization of the substrate. However, in some cases, Plk1
activity is known to have a striking effect on the intracellular
distribution of its substrates. One of these cases is cohesin,
a protein complex that physically connects sister chromatids
until these are separated during anaphase. To allow the reso-
lution of sister chromatids, cohesin has to be removed from
chromosome arms, a process that is already initiated during
prophase in vertebrate cells—unlike in yeast, where cohesin
is removed from the entire length of the chromosome at the
metaphase-to-anaphase transition (Nasmyth and Haering,
2005). To facilitate the resolution of chromosome arms during
prophase in animal cells, Plk1 phosphorylates the SA2 subunit
of cohesin complexes and thereby promotes the dissociation
of cohesin from DNA by an unknown mechanism (Gimenez-
Abian et al., 2004; Hauf et al., 2005; Losada et al., 2002; Su-
mara et al., 2002). To allow correct chromosome alignment
during metaphase, cohesin at centromeres is largely protected
from this process by the Sgo1 protein, which recruits protein
phosphatase 2A (PP2A) to this site, where PP2A is believed
to revert SA2 phosphorylation by Plk1 (Kitajima et al., 2006;
McGuinness et al., 2005; Tang et al., 2006). A similar situation
has been observed for PICH and Plk1 itself, which are normally
enriched at kinetochores but are found along chromosome
arms if Plk1 is inhibited (Baumann et al., 2007; Santamaria
Figure 3. Model for the Control of Plk1 Recruitment to the
Spindle Midzone and for Plk1’s Function in Eliciting the Onset
of Cytokinesis in Human Cells
(A)PhosphorylationofPrc1byCdk1/cyclinBprevents the interactionofPlk1
with Prc1 at metaphase. Likewise, Cdk1 prevents the formation of the cen-
tral spindle and targets Ect2 to hinder its binding to the centralspindlin sub-
unit HsCyk-4 (also known as MgcRacGAP). When Cdk1 activity declines
after anaphase onset, Plk1 phosphorylates Prc1 to create a docking site
for its ownPBDdomain ina self-primingmanner. This leads toPlk1 targeting
to the spindle midzone and might elicit further rapid Plk1 accumulation
through a positive feedback loop mechanism. Subsequently, Plk1 activity
promotes the interaction of Ect2 with HsCyk-4 via an unknown molecular
mechanism. Binding of Ect2 to HsCyk-4 recruits Ect2 to the central spindle
andmight activateGEF function. Finally, this could trigger the accumulation
ofGTP-bound activeRhoA, the formation of the contractile ring, and the on-
set of cleavage furrow ingression/cytokinesis at the equatorial cortex.
(B) Twomodels for the molecular basis of Plk1-induced complex formation
between HsCyk-4 and Ect2. Please note that for reasons of simplicity, the
tandem arrangement of Ect20s two BRCT domains is illustrated as a single
BRCTunit. Phosphorylation of Ect2 byPlk1 could induce the dissociation of
theN-terminal BRCTdomains from theC-terminal part of themolecule (left).
Alternatively, phosphorylation of HsCyk-4 in the N-terminal region could
provide adocking site for Ect20sBRCTdomain (right). In bothcases, binding
of Ect2 to HsCyk-4might stimulate Ect20s GEF activity. Please note that the
two distinct models presented in this figure are not mutually exclusive.
Mklp1, the constitutive interaction partner of HsCyk-4, is not shown in this
figure.
et al., 2007). It is unknown how Plk1 activity mediates the
selective removal of PICH and Plk1 from chromosome
arms or prevents the association of PICH and Plk1 with
these regions in the first place.
Anaphase and Telophase—Plk1’s Dark Corner
Due to Plk1’s essential role in centrosome and kinetochore
function interfering with Plk1 by RNAi, expression of domi-
nant-negative versions and mutant alleles traps animal cells
in early mitosis with an activated spindle assembly check-
point (Seong et al., 2002; Sumara et al., 2004; Sunkel andGlover,
1988; van Vugt et al., 2004b) (Figure 2). This mitotic arrest has
precluded the direct analysis of Plk1 function after anaphase on-
set, e.g., during cytokinesis (Barr et al., 2004; van Vugt and Me-
dema, 2005).
The localization pattern of Plk1 at the anaphase spindle
(Golsteyn et al., 1995) (Figure 1B) has fueled the hypothesis
that Plk1 might be a key regulator of cell cleavage in animal cells.
This notion was reinforced by studies in both budding and fission
yeast (Lee and Erikson, 1997; Ohkura et al., 1995; Yoshida et al.,
2006). Moreover, the weak spindle assembly checkpoint in
Drosophila spermatocytes permitted the observation of defects
in cytokinesis caused by a hypomorphic polo allele in flies
(Carmena et al., 1998). However, unearthing this function of
Plk1 in mammalian cells had to await the development of chem-
ical tools that allowed rapid, specific, and complete inactivation
of Plk1 at anaphase onset (Randall et al., 2007; Taylor and
Peters, 2008).
Several independent studies have now used chemical tools to
specifically block the catalytic activity of Plk1 during anaphase
(Brennan et al., 2007; Burkard et al., 2007; Petronczki et al.,
2007; Santamaria et al., 2007). These studies have identified
Plk1 as an essential early regulator of cytokinesis and anaphase
spindle elongation in mammalian cells (Figure 3A). Together with
a very detailed analysis of how Plk1 is targeted to the anaphase650 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.
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expanded our knowledge of events occurring during the last
stages of cell division and suggest that Plk1’s importance in get-
ting cells separated falls nowhere short of its long-appreciated
earlier role in preparing cells for division.
Completing Cell Division during Cytokinesis
After the segregation of sister genomes during anaphase, animal
cells divide their cytoplasm by ingression of a cleavage furrow
midway between the two masses of chromosomes (Barr and
Gruneberg, 2007; Glotzer, 2005). This process, called cytokine-
sis, completes cell division and upon membrane fusion yields
two physically distinct daughter cells. In animal cells, cleavage
furrow ingression is driven by the assembly and tightening of
the contractile ring, a cortical actomyosin network, at the cell
equator. As in the case of many other actin-dependent pro-
cesses, a Rho-family GTPase acts as a key switch during
cytokinesis in many animal cell types (Piekny et al., 2005). Local
activation of the GTPase RhoA at the equatorial cortex controls
the assembly and ingression of the contractile ring by promoting
myosin II activity and actin polymerization (Figure 3A).
The anaphase spindle serves as a landmark during cytokinesis
(Barr andGruneberg, 2007; D’Avino et al., 2005) and plays a cen-
tral role in activating RhoA and positioning of the cleavage furrow
(Bement et al., 2005; Bringmann and Hyman, 2005; Kamijo et al.,
2006; Nishimura and Yonemura, 2006). Both microtubule asters
and microtubules extending toward the equatorial cortex and
cell center are important for placing the cleavage plane (Bring-
mann and Hyman, 2005; Werner et al., 2007). Upon anaphase
onset, bundled arrays of overlapping antiparallel microtubules
form a structure between the two sets of segregated chromo-
somes that is referred to as the spindle midzone (or central
spindle). Together with numerous other cytokinesis regulators,
a conserved protein complex called centralspindlin localizes to
the spindle midzone in anaphase and is important for the forma-
tion of that structure (Mishima et al., 2002). Centralspindlin is
a heterotetramer, which is composed of two molecules of the
kinesin Mklp1 (also known as Kif23) and two molecules of the
RhoGAP protein HsCyk-4 (also known as MgcRacGAP) (Pavi-
cic-Kaltenbrunner et al., 2007). At anaphase, HsCyk-4 binds
the evolutionarily conserved Rho guanine-nucleotide exchange
factor (RhoGEF) Ect2 and thereby recruits Ect2 to the central
spindle (Nishimura and Yonemura, 2006; Somers and Saint,
2003; Yuce et al., 2005; Zhao and Fang, 2005). This interaction
is thought to enhance Ect20s exchange activity (Yuce et al.,
2005). Studies by several groups have indicated that the pres-
ence of the HsCyk-4/Ect2 complex on peripheral central spindle
microtubules in close proximity to the equatorial complex acti-
vates RhoA and thereby triggers the initiation of cytokinesis
(Nishimura and Yonemura, 2006; Somers and Saint, 2003;
Yuce et al., 2005; Zhao and Fang, 2005). Thus, the HsCyk-4/
Ect2 protein complex might link the anaphase spindle to the
equatorial cell cortex to stimulate cleavage furrow formation
(Figure 3A).
Chemistry puts Polo-like Kinase 1 on the
Cytokinesis Map
In addition to its basic role in cell division and proliferation, cyto-
kinesis plays a key role in preventing genomic instability andaneuploidy (Ganem et al., 2007), both hallmarks of cancer cells.
Therefore, cytokinesis has to be coordinated with other mitotic
events like chromosome segregation in a spatial and temporal
manner. Until recently, our understanding of how mitotic
kinases, which act in late mitosis after the inactivation of Cdk1,
control contractile ring formation and coordinate mitotic
progression with cortical cytoskeletal activity has been rather
poor. In the case of Plk1, this has now changed.
Four independent studies have used a genetically engineered,
analog-sensitive allele in combination with an allele-specific
inhibitor (Burkard et al., 2007) or the recently developed small-
molecule chemical Plk1 inhibitors BI 2536, BTO-1, and TAL
(Brennan et al., 2007; Petronczki et al., 2007; Santamaria et al.,
2007) to probe late mitotic functions of Plk1 in human cells.
Acute inhibition of Plk1 by addition of these compounds at the
metaphase-to-anaphase transition was used as a means of
avoiding the early mitotic arrest typically associated with genetic
ablation of Plk1 (Figure 4A). Under these conditions, most cells
succeeded to segregate sister chromatids to opposite poles
and progressed to later mitotic stages, allowing scrutinization
of potential novel functions of Plk1. Remarkably, these studies
yielded exciting and uniform results despite the use of different
chemical genetic and chemical biology tools.
Acute inactivation of Plk1 at themetaphase-to-anaphase tran-
sition blocked the initiation of cytokinesis by preventing ingres-
sion of the cleavage furrow (Brennan et al., 2007; Burkard
Figure 4. Plk1 Controls Spindle Elongation at Anaphase B and
Initiation of Cytokinesis in Human Cells
(A) Addition of Plk1 inhibitors at themetaphase-to-anaphase transition enables
the analysis of Plk1’s late mitotic functions.
(B) Acute inhibition of Plk1 by BI 2536 prevents anaphase B spindle elongation
in HeLa cells (images reproduced from Brennan et al., 2007). The pole-to-pole
distance is indicated by a white double-headed arrow.
(C) Failure of RhoA accumulation at the equatorial cortex and absence of
cleavage furrow ingression following Plk1 inhibition in HeLa cells.
(D) Tetraploid and binucleated human epithelial cells (hTERT-RPE1) as a result
of acute Plk1 inhibition and cytokinesis failure during the preceding cell
division.Developmental Cell 14, May 2008 ª2008 Elsevier Inc. 651
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a consequence, cells treated with the inhibitor failed to
divide and exited mitosis as tetraploid binucleates (Figure 4D).
Surprisingly, inhibition of Plk1 during anaphase did not notice-
ably interfere with exit from mitosis. In contrast to the situation
in Xenopus egg extracts, budding yeast, and fission yeast, where
the Polo orthologs Plx1, Cdc5, and plo1 play important roles in
promoting mitotic exit (Descombes and Nigg, 1998; Jensen
et al., 2002; Krapp et al., 2004), the activity of Plk1 at anaphase
appears to be dispensable for the timely return of human mitotic
cells to interphase. These results suggest that Plk1 specifically
controls the onset of cytokinesis during late mitosis in human
cells. Observations underpinning this function of Plk1 during cy-
tokinesis have been made in human cancer, human noncancer,
and rat kangaroo cells (Brennan et al., 2007; Burkard et al., 2007;
Petronczki et al., 2007; Santamaria et al., 2007). This suggests
that the function of Plk1 in this process is not restricted to cancer
cells and might be conserved in vertebrate and, considering the
earlier results in Drosophila spermatocytes (Carmena et al.,
1998), possibly even metazoan cells.
Plk1 Controls the Initiation of Cytokinesis through
the RhoGEF Protein Ect2 and the GTPase RhoA
Which events in the pathway that culminates in cleavage furrow
ingression are perturbed following acute Plk1 inhibition during
anaphase? Careful inspection revealed that cells treated with
Plk1 inhibitors failed to assemble the contractile ring and to
accumulate RhoA, the upstream regulator of the contractile
ring function, at the equatorial cortex during anaphase (Brennan
et al., 2007; Burkard et al., 2007; Petronczki et al., 2007; Santa-
maria et al., 2007) (Figure 4C). These findings readily explain the
absence of cleavage furrow ingression after acute Plk1 inactiva-
tion and demonstrate that Plk1 activity is essential for the earliest
cortical events of cytokinesis in human cells. Since RhoA locali-
zation does not require an intact contracile ring (Bement et al.,
2005; Burkard et al., 2007; Nishimura and Yonemura, 2006),
defective localization of RhoA suggests that Plk1 controls the
initiation of cytokinesis via RhoA.
The search for the culprit responsible for this phenotype did
not have to go much further. While Plk1 activity was dispensable
for the localization of both centralspindlin subunits Mklp1 and
HsCyk-4 to the spindle midzone, recruitment of Ect2, the GEF
protein critical for Rho activation, was abolished when anaphase
cells were treatedwith Plk1 inhibitors (Brennan et al., 2007; Burk-
ard et al., 2007; Petronczki et al., 2007; Santamaria et al., 2007).
Thus, despite the accumulation of Ect20s ‘‘anchor’’ protein
HsCyk-4 at the central spindle, Ect2 was unable to localize to
this structure in the absence of Plk1 activity. These findings
strongly suggested that Plk1 kinase activity promotes the inter-
action between the two proteins. Indeed, biochemical experi-
ments demonstrated that acute inhibition of Plk1 by BI 2536
addition during anaphase prevented complex formation be-
tween HsCyk-4 and Ect2 (Petronczki et al., 2007). These results
provided a molecular explanation for the failure of equatorial
RhoA accumulation and the early cytokinesis block observed af-
ter Plk1 inactivation and identified Plk1 as an essential regulator
of the Ect2-RhoA network that appears to link the anaphase
spindle to the cell cortex to trigger the initiation of cytokinesis
(Figure 3A). The failure of Ect2 binding to HsCyk-4 and conse-652 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.quential defect in Ect2 recruitment and possibly activation fol-
lowing inhibition of Plk1might leave the central spindle incapable
of activating RhoA and stimulating furrowing at the equator. Con-
sistent with this model, the localization of Plk1 itself to the central
spindle (see below) at anaphase puts this kinase in the right place
at the right time to regulate the interaction between HsCyk-4 and
Ect2 (Figure 3A). It is tempting to speculate that localization of
Plk1 to this landmark position for cytokinesis might contribute
to the correct timing and placing of the cleavage furrow.
Molecular Control of Cytokinesis by Plk1—Two
Possible Scenarios
The challenge for the future will be to determine how Plk1 kinase
activity induces complex formation between HsCyk-4 and Ect2
on a molecular level. Clues from previous biochemical experi-
ments and Ect20s domain architecture suggest two attractive
but not mutually exclusive models (Figure 3B). While Ect20s
active GEF domain is located in the C-terminal half of the protein,
the N terminus of Ect2 contains two tandem copies of a BRCA1
C-terminal (BRCT) domain that mediate the interaction with
HsCyk-4 (Somers and Saint, 2003; Yuce et al., 2005). Biochem-
ical studies have shown that the N-terminal BRCT domains can
interact with C-terminal half of the protein (Kim et al., 2005). This
intramolecular interaction inhibits Ect20s GEF function and could
prevent the BRCT domains from binding to HsCyk-4. Thus, both
targeting of Ect2 to the spindle midzone and its GEF activity
might be subject to intramolecular autoinhibition. Phosphoryla-
tion of Ect2 by Plk1 at the central spindle during anaphase could
dissociate the N-terminal from the C-terminal half and thereby
catch two birds with one stone (Figure 3B, left). Ect20s BRCT
domains would be free to interact with HsCyk-4 and target
Ect2 to the central spindle. At the same time, Ect20s GEF domain
would be activated and could stimulate contractile ring formation
at the equator via RhoA (Figure 3B, left). Several observations
provide support for this hypothesis. Ect2 is an excellent target
for phosphorylation by Plk1 in vitro, and both proteins can asso-
ciate with each other when overexpressed in cells (Niiya et al.,
2006). Furthermore, Ect2 is specifically phosphorylated shortly
before and during mitosis, and these modifications strongly
enhance Ect20s exchange activity in vitro (Tatsumoto et al.,
1999). Lastly, indirect evidence suggests that phosphorylation
is capable of altering the conformation of Ect2 (Hara et al., 2006).
The alternative model is based on the fact that two tandem
BRCT domains can act as a phosphopeptide binding module
(Manke et al., 2003; Yu et al., 2003) and assumes that HsCyk-4
is the key target of Plk1 for promoting HsCyk-4/Ect2 complex
formation (Figure 3B, right). During anaphase, when both cen-
tralspindlin and Plk1 begin to accumulate at the spindle mid-
zone, Plk1 might phosphorylate the N-terminal half of HsCyk4
that is known to contain the Ect2 interacting region (Somers
and Saint, 2003; Yuce et al., 2005). This might create a phospho-
peptide sequence that is recognized by Ect20s BRCT domains.
Binding of the tandem BRCT domains to this phosphopeptide
mark could induce HsCyk-4/Ect2 complex formation and
thereby target Ect2 to the central spindle (Figure 3B, right).
Strong support for this model comes from the finding that the
interaction between HsCyk-4 and Ect20s BRCT domains is de-
pendent on phosphorylation of, most likely, HsCyk-4 (Yuce
et al., 2005). Moreover, the N-terminal half of HsCyk-4 contains
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Finally, the amino acid residues that directly contact the phos-
phate group in the phosphopeptide cocrystal structures of
BRCA1 and MDC1 BRCT domains appear to be conserved in
Ect20s BRCT domains, indicating that this part of the protein
does indeed function as a phospho-binding module.
Irrespective of whether none, one, or both of the Plk1-depen-
dent molecular mechanisms described above recruit Ect2 to the
spindle midzone, it remains to be seen whether Plk1 associates
with either HsCyk-4 or Ect2 during anaphase in order to achieve
its task. In any case, we should stay tuned to hear more details
soon. The availability of Plk1 inhibitors (Randall et al., 2007;
Taylor and Peters, 2008) will undoubtedly facilitate the identifica-
tion of the critical Plk1 target(s) and Plk1-dependent mecha-
nisms operating during cytokinesis. Only once these results
are available and phosphorylation sites on Plk1 target proteins
can be altered to abolish or mimic the modification will it be pos-
sible to ultimately test whether Plk1’s main role in initiating cyto-
kinesis is to promote HsCyk-4/Ect2 complex formation.
Centrosomes and astral microtubules are both regulated by
Plk1 (see above) and involved in cytokinesis (Barr and Grune-
berg, 2007). Furthermore, Plk1 appears to influence the function
of the anaphase microtubules and the stable association of
several proteins with the central spindle (see below). Thus, it
is possible that perturbations of centrosomal or anaphase
spindle-related functions of Plk1 indirectly contribute to the
severe cytokinetic defect observed following Plk1 inactivation
at anaphase. Currently, the best evidence for a direct link
between Plk1 activity and contractile ring assembly is the phos-
pho-dependent and Plk1-dependent interaction of Ect2 with
HsCyk-4.
The early block in cytokinesis upon acute Plk1 inhibition
(Brennan et al., 2007; Burkard et al., 2007; Petronczki et al.,
2007; Santamaria et al., 2007) closely resembles the phenotype
obtained by RNAi-mediated depletion of HsCyk-4 or Ect2 (Nish-
imura and Yonemura, 2006; Yuce et al., 2005; Zhao and Fang,
2005). Thus, it emphasizes the importance of the HsCyk4/Ect2
interaction that appears to lie at the heart of cleavage furrow
ingression in many animal cells (Figure 3A). Consistent with
this notion, forcing RacGAP50C, the Drosophila homolog of
HsCyk-4, to localize to the plasma membrane leads to ana-
phase-specific and massive ectopic furrowing that is dependent
on the fly homolog of Ect2 Pebble (D’Avino et al., 2006). Further-
more, the Plk1 inhibition phenotype provides support for the
spindle midzone stimulation model of cytokinesis (D’Avino
et al., 2005), at least in human somatic cells.
Phenotypic comparison suggests that preventing formation of
the HsCyk-4/Ect2 complex or removal of either complex partner
has more drastic consequences for cytokinesis than mere delo-
calization of the intact complex (Yuce et al., 2005). It is therefore
tempting to speculate that the Plk1-mediated binding of Ect2 to
HsCyk-4 not only targets Ect2 to the central spindle but also
stimulates Ect20s GEF activity. Testing this hypothesis in vitro
and measuring the level and distribution of GTP-bound active
RhoA in anaphase cells that were treated with Plk1 inhibitors
are important experiments to deepen our understanding of the
events leading up to cleavage furrow formation in animal cells.
Results from expression of dominant-negative Ect2 variants
have cast doubt upon the significance of Ect2 binding toHsCyk-4 and Ect2 recruitment to the spindle midzone for the
early steps of cytokinesis (Chalamalasetty et al., 2006). Specifi-
cally abolishing the interaction of Ect2with HsCyk-4 bymutating,
yet unidentified, Plk1 target sites might make it possible to test
the importance of Ect2 binding to its anchor and Ect2 localization
to the central spindle.
Plk1 Window-of-Function and Relation to Fellow Mitotic
Kinases during Cytokinesis
Time-lapse analysis of cells treated with the Plk1 inhibitor TAL at
different times during mitosis separated early from late mitotic
roles of Plk1 and defined the window-of-function of Plk1 during
cytokinesis (Santamaria et al., 2007). As expected, inhibition of
Plk1 prior to metaphase resulted in monopolar spindles and
a prometaphase-like arrest (Figure 2A). The results of TAL addi-
tion to metaphase and anaphase cells showed that Plk1 activity
is not only essential for the initiation of cytokinesis (see above)
but also for successful furrow ingression once constriction has
commenced. Whether this latter function just demonstrates
a continuous requirement of Plk1 for the activation of the
HsCyk-4/Ect2/RhoA pathway during furrow ingression or re-
flects a hitherto unknown role of Plk1 remains to be addressed.
Plk1 might influence furrow ingression through Rock2 kinase,
a downstream effector of RhoA and Plk1 substrate (Lowery
et al., 2007). Interestingly, inactivation of Plk1 after furrow ingres-
sion had been completed did not prevent successful cell separa-
tion, suggesting that Plk1 activity might be dispensable for the fi-
nal abscission stage of cytokinesis (Santamaria et al., 2007). This
result is noteworthy and potentially controversial, since several
other reports have postulated important functions for Plk1 during
abscission (Fabbro et al., 2005; Litvak et al., 2004). Clearly, more
experiments are required to firmly establish whether Plk1 plays
a role during abscission or not.
Small-molecule compounds do not only allow precise timing
of protein inactivation in vivo but also enable chemical epistasis
experiments that address the function of two enzymes in relation
to each other by combining inhibitors against two different
enzymes. Prior to anaphase onset, cyclin-dependent kinase 1
(Cdk1), the enzyme that establishes the mitotic state in eukary-
otic cells, collectively inhibits chromosome segregation, cytoki-
nesis, and mitotic exit (Barr and Gruneberg, 2007; Eggert et al.,
2006). Only when Cdk1 is turned off by destruction of its regula-
tory subunit cyclin B at the hands of the APC/C are cells able to
divide and return to interphase. Since Plk1 is known to phos-
phorylate subunits of the APC/C (Kraft et al., 2003), it was
formerly possible that Plk1 regulated cytokinesis merely indi-
rectly by ensuring that Cdk1 is efficiently inactivated. However,
simultaneous and acute inhibition of both Cdk1 and Plk1 during
anaphase did not suppress the early cytokinesis block observed
after inactivation of Plk1 alone (Petronczki et al., 2007). This and
further experiments showed that once Cdk1 has been inacti-
vated and cells are poised to exit mitosis, Plk1 directly acts on
the cytokinetic machinery to induce cleavage furrow ingression
(Figure 3A). In a similar experimental setup, results from simulta-
neous inhibition of Plk1 and Aurora B, another key mitotic kinase
operating during cytokinesis, suggested that the two kinases
contribute to successful cell cleavage via different molecular
mechanisms and possibly via different substrates (Petronczki
et al., 2007).Developmental Cell 14, May 2008 ª2008 Elsevier Inc. 653
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of Ect2 with HsCyk-4. Phosphorylation of Ect2 by Cdk1 appears
to prevent binding of Ect2 to its partner before anaphase (Yuce
et al., 2005) (Figure 3A). This might be one of the mechanisms
by which Cdk1 ensures that cell cleavage does not start before
sister chromatids have been segregated to the poles. Only
once Cdk1 has been inactivated at the metaphase-to-anaphase
transition might Plk1 be able to promote the binding of Ect2 to
HsCyk-4. Thus, similar to the localization of Plk1 itself to the
spindle midzone (Neef et al., 2007) (see below, Figure 3A),
a Cdk1-Plk1 ‘‘switch’’ might regulate the association state of
HsCyk-4 and Ect2 to be either OFF (before anaphase) or ON
(after anaphase).
In contrast to the results obtained by acute Plk1 inhibition,
earlier studies using RNAi-mediated depletion (van Vugt et al.,
2004b) and expression of a dominant-negative version of Plk1
(Seong et al., 2002), two less definitive ways of abolishing protein
function, have suggested that Plk1 is dispensable for the early
steps of cytokinesis. Off-target effects are a major concern
when employing small-molecule inhibitors to study biological
processes. However, the consistent results obtained by allele-
specific inhibition (Burkard et al., 2007), which can be considered
the ‘‘golden standard’’ of chemical biology, and by using three
structurally unrelated inhibitors of Plk1 (Brennan et al., 2007; Pet-
ronczki et al., 2007; Santamaria et al., 2007) leave little doubt that
Plk1 is essential for the initiation of cytokinesis in human cells.
Althoughwe currently lack knowledge of themolecular details,
the use of small-molecule inhibitors of Plk1 has provided com-
pelling evidence that Plk1 triggers the initiation of cytokinesis
by promoting the recruitment of the RhoGEF protein Ect2 to
the spindle midzone during anaphase (Figure 3). Thus, the appli-
cation of chemical genetics and biology tools has led to the iden-
tification of a novel late mitotic function of Plk1 in human cells.
This role had been suggested by earlier genetic studies in fission
yeast and Drosophila but had hitherto been masked in human
cells by Plk1’s well-established earlier roles during cell division
(Figure 1B). This case undoubtedly highlights the power and ad-
vantages of fast acting small-molecule inhibitors, which do not
rely on slow mRNA or protein turnover, for dissecting biological
processes at high temporal resolution.
Recruitment of Plk1 to the Spindle Midzone—Cdk1
Governess versus Self-Control
While Plk1 still occupies kinetochores in late mitosis, most of the
protein accumulates at the central spindle and midbody during
anaphase and telophase (Barr et al., 2004; Golsteyn et al.,
1995) (Figure 1B). This localization is mediated by Plk1’s PBD
(Jang et al., 2002), suggesting that binding of the PBD to a phos-
phorylated and hence ‘‘primed’’ docking protein recruits Plk1 to
the spindle midzone. Recently, the purification of Plk1 from
enriched anaphase spindles led to the identification of themicro-
tubule-bundling protein Prc1 (Protein regulator of cytokinesis 1)
as the major docking factor for Plk1 at the central spindle (Neef
et al., 2007). Work on Polo and Fascetto, the Drosophila homo-
logs of Plk1 and Prc1, has come to similar conclusions (D’Avino
et al., 2007), suggesting that the docking partner for Polo-like
kinases at the central spindle might be conserved in animal cells.
Prc1 localizes to the central spindle at anaphase and regulates
the architecture of this structure (Barr and Gruneberg, 2007).654 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.Although Prc1 occupies spindlemicrotubules already in earlymi-
tosis, Plk1 is recruited to the central spindle only after anaphase
onset. Recent experiments in human cells have revealed the
mechanistic basis for this regulation. Phosphorylation of Prc1
by Plk1 during anaphase creates a binding site for Plk1’s PBD
leading to central spindle recruitment of the kinase (Neef et al.,
2007) (Figure 3A). This self-priming activity of Plk1 is reminiscent
of Plk1 kinetochore localization via PBIP1 (Kang et al., 2006) (see
above) and might create a positive feedback loop eliciting rapid
accumulation of Plk1 at the spindlemidzone. Consistent with this
model, inhibition of Plk1 activity abolishes the localization of Plk1
(Brennan et al., 2007; Burkard et al., 2007; Petronczki et al.,
2007; Santamaria et al., 2007). Prior to anaphase onset, Cdk1
phosphorylates Prc1 on distinct sites and thereby prevents
Plk1 from acting on Prc1 and creating a PBD docking site (Fig-
ure 3A). Thus, only when Cdk1 activity declines at anaphase,
Plk1 is able to bind to Prc1 and localize to the spindle midzone.
While Cdk1 can act as a priming kinase for Plk1 recruitment to
substrates in early mitosis, it inhibits the interaction of Plk1
with late mitotic targets. These findings suggest that the activa-
tion state of Cdk1 controls the interaction partner choice of Plk1
(Neef et al., 2007). Although this is so far the only example of how
substratesmight be temporally ordered by differential phosphor-
ylation of PBD docking sites, it might be a general mechanism of
Plk1 regulation, and it will be interesting to see how many more
examples will be found in the future. It is noteworthy that recruit-
ment of Plk1 to the central spindle does not only require Prc1 and
Plk1 kinase activity but also the mitotic kinesin and spindle mid-
zone component Mklp2 (Neef et al., 2003). Currently, it is unclear
how Prc1 and Mklp2 cooperate to bring about the localization of
Plk1 to the center of anaphase spindle.
Considering the essential role of Plk1 in promoting HsCyk-4/
Ect2 complex formation and cleavage furrow formation, it is
likely that its localization to the central spindle at anaphase con-
tributes to regulation of cleavage plane specification in time and
space. Docking an enzyme that controls an essential step in the
pathway leading to the initiation of cytokinesis to the spindle
midzone could help to restrict cleavage furrow formation to the
equator at anaphase. Consistent with this notion, preventing
the docking of Plk1 at the central spindle blocks successful
cytokinesis (D’Avino et al., 2007; Neef et al., 2007). However,
while the activity of Plk1 is clearly essential for cleavage furrow
formation, delocalization of the active kinase appears to cause
a weaker phenotype (D’Avino et al., 2007; Neef et al., 2007).
This suggests that delocalized Plk1 might still, albeit less effi-
ciently, act on factors that associate with the spindle midzone
independently of Plk1, e.g., HsCyk-4. Thus, localization of these
factors might act, to some extent, redundantly to Plk1’s localiza-
tion for initiating cytokinesis and positioning the cleavage plane.
Whether docking of Plk1 to the spindle midzone is important for
efficient Ect2 recruitment to the same structure remains to be
addressed. Furthermore, it will be important to measure the spa-
tial distribution of activity of Plk1 during late mitosis using intra-
cellular protein sensors that are targeted to the mitotic spindle.
Given recent findings in budding yeast (Queralt et al., 2006),
the possibility should not be neglected that cell cycle-dependent
alterations in the subcellular localization or activity of protein
phosphatases that antagonize Plk1 might contribute to the net
result of these phosphorylation-dependent events. Such
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centromeres by PP2A (see above) and might involve MYPT1/
PP1C, which antagonizes Plk1 at centrosomes in early mitosis
(see above) (Yamashiro et al., 2008).
Plk1 might also play additional roles at the central spindle
besides regulating HsCyk-4/Ect2 complex formation. Although
Plk1 inhibition does not abolish central spindle formation, Plk1
is required for the stable localization of a number of spindle
midzone components and cytokinesis regulators, including
Mklp2 and the Aurora B/chromosomal passenger protein com-
plex (Petronczki et al., 2007; Santamaria et al., 2007). More ex-
periments are required to test the importance of Plk1 for central
spindle structure and function.
Not only does targeting Plk1 to the spindlemidzone during late
mitosis appear to be important, but so does keeping it away from
microtubules prior to anaphase onset. Experimentally induced
precocious binding of Plk1 to Prc1 resulted in the formation of
monopolar spindles and caused cells to arrest in mitosis (Neef
et al., 2007). This result underscores the need for tight control
over the localization of Plk1 throughout cell division.
Increasing the Distance between Sisters—Spindle
Elongation at Anaphase B
Chromosome segregation in animal cells is a two-step process.
First, sister chromatids aremoved to opposite poles in a process
called anaphase A. Thereafter and concomitantly with the initia-
tion of cytokinesis, the anaphase spindle elongates and the pole-
to-pole distance increases (anaphase B). Careful time-lapse
analysis revealed that cells treated with Plk1 inhibitors failed to
elongate the spindle at anaphase B (Brennan et al., 2007)
(Figure 4B). Thus, triggering cleavage furrow ingression appears
not to be the only important late mitotic function of Plk1 in animal
cells. Washout experiments showed that alleviating the inhibition
of Plk1 long after anaphase onset allowed the recovery of cleav-
age furrow formation but not anaphase B spindle elongation
(Brennan et al., 2007). These results indicate that cytokinesis
and anaphase B spindle elongation are separable and possibly
independent processes that are nevertheless both regulated
by Plk1. The action of Plk1 might therefore couple chromosome
segregation to the division of the cytoplasm during cytokinesis
(Figure 3A). Several key questions regarding Plk1’s role in ana-
phase B remain to be addressed. Is Plk1 localization to the cen-
tral spindle important for spindle elongation during anaphase B?
How does Plk1 activity control spindle elongation at the molec-
ular level? Astral microtubules, motor proteins at the spindle
poles or at the central spindle, and RhoA in combination with
its downstream effectors are all plausible candidates.
Of Yeast and Men—A Conserved Link between
Polo and Rho during Cell Division?
The process of cytokinesis in animal cells differs in several key
aspects from the analogous process in budding yeast. For
example, cytokinesis in Saccharomyces cerevisiae involves the
build-up of some contractile ring components already at the
G1/S transition and does not rely on the microtubule cytoskele-
ton (Balasubramanian et al., 2004).
Despite these discrepancies, the recent analysis of human
Plk1 during cytokinesis has revealed striking conceptual paral-
lels to the results of an earlier study that addressed the functionof the budding yeast Polo-like kinase Cdc5 during anaphase
(Yoshida et al., 2006) (Figure 5). The unsurpassed power of yeast
genetics in combination with biochemistry appears to have been
faster yet again. A series of elegant experiments revealed that
Cdc5 controls the formation of the contractile ring and the acti-
vation of Rho1 (RhoA) at the bud neck by phosphorylating and
thereby targeting the two GEF proteins Tus1 and Rom2 to the
division site (Yoshida et al., 2006) (Figure 5). Although Tus1
and Rom2 do not appear to be related to Ect2 in sequence,
and mechanistic details might differ, these findings bear remark-
able similarity to the situation in human cells where Plk1 regu-
lates RhoA and cleavage furrow formation by targeting the GEF
protein Ect2 to the central spindle. Thus, it is tempting to specu-
late that the connection between Polo-like kinase and Rho might
be a conserved feature of cell division in yeast and animal cells
(Figure 5). To put this hypothesis to the test, it will be necessary
to scrutinize the anaphase function of Polo in invertebrate cells.
Budding yeast Cdc5 regulates the activity of Rho1 not only at
the site of division via Tus1 and Rom2 but also globally through
a distinct mechanism (Yoshida et al., 2006). Recent work in
Caenorhabditis elegans has shown that the polarization of the
anteroposterior axis in the nematode zygote involves the worm
homologs of Ect2, HsCyk-4, and RhoA (Jenkins et al., 2006) (Fig-
ure 5). It will be exciting to see whether the regulation of Rho by
Polo-like kinase through GTPase regulators, such as GEF and
GAP proteins, is restricted to mitosis in animal cells or whether
it also operates more globally and in other cellular contexts,
e.g., in cell polarity.
Plk1 as a Potential Target for Cancer Therapy
Recently, Plk1 has attracted attention as a potential target for
anticancer therapy. The reason for considering Plk1 as a thera-
peutic target has primarily been that Plk1 activity is essential
for cell division, and pharmacologic inactivation of Plk1 might
be possible because the ATP-binding pocket of protein kinases
is generally well suited for the design of potent small-molecule
inhibitors. Based on this rationale, several small-molecule
Figure 5. Comparison of Signaling Pathways Controlling Rho
Activity in Different Biological Contexts and OrganismsDevelopmental Cell 14, May 2008 ª2008 Elsevier Inc. 655
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Reviewinhibitors of Plk1 have recently been developed (Lansing et al.,
2007; Lenart et al., 2007; McInnes et al., 2006; Peters et al.,
2006; Santamaria et al., 2007; Steegmaier et al., 2007) (reviewed
in Taylor and Peters, 2008). Some of these, BI 2536 (Lenart et al.,
2007; Steegmaier et al., 2007), TAL (Santamaria et al., 2007)
and a tiophene benzimidazole (‘‘compound 1;’’ Lansing et al.,
2007) inhibit Plk1 with high potency (IC50s between 0.9 and 19
nM) and reasonable specificity. However, all of these com-
pounds can also inhibit the Plk1-related kinases Plk2 and Plk3,
and it thus needs to be kept in mind that the inhibition of these
enzymes could contribute to phenotypes obtained with Plk1 in-
hibitors.
It has also been argued that Plk1 could be an attractive anti-
cancer target because overexpression of Plk1 has been
observed in a number of human tumors (reviewed in Eckerdt
et al., 2005; Strebhardt and Ullrich, 2006). These studies re-
vealed that tumors often contain more cells in which Plk1 is
expressed than normal tissues. However, since Plk1 is only
expressed in proliferating cells (Hamanaka et al., 1994; Holtrich
et al., 1994), this situation could simply reflect an increased pro-
liferative index in tumor tissues and does not necessarily mean
that tumors contain higher amounts of Plk1 at the single-cell level
than normal tissues.
It is also unknown if the proliferation of tumor cells is more
dependent on Plk1 than the proliferation of normal cells. Several
studies have suggested that this may be the case because tumor
cells were found to bemore sensitive to depletion of Plk1 byRNAi
than nontransformed cells (Liu et al., 2006; Salvatore et al., 2007),
but it is difficult to know if Plk1 depletion in nontransformed cells
was equally efficient as in tumor cells. Experiments with BI 2536
(Lenart et al., 2007; Steegmaier et al., 2007) and with TAL (San-
tamaria et al., 2007) indicate that Plk1 is also needed for the
division of nontumor cells. It is nevertheless possible that some
tumor cells are particularly sensitive to Plk1 inhibition because
genetic studies in yeast have shown that tetraploid cells require
higher amounts of the Plk1 ortholog Cdc5 than diploid cells
(Storchova et al., 2006). In tetraploid yeast cells, the frequency
of erroneous chromosome attachments to the mitotic spindle
is also increased (Storchova et al., 2006). It is therefore possible
that Cdc5 is particularly important in tetraploid cells to allow
proper attachment of the increased number of kinetochores to
the spindle. By analogy, it will be interesting to test if the sensitiv-
ity of human tumor cells to Plk1 inhibition correlates with their
ploidy status, which is often abnormal in solid tumor cells.
Both RNAi and small-molecule inhibitor experiments have
shown that inactivation of Plk1 kills cultured tumor cells very ef-
ficiently (Gray et al., 2004; Lenart et al., 2007; Spankuch-Schmitt
et al., 2002; Steegmaier et al., 2007; Sumara et al., 2004). As
mentioned above, Plk1 inactivation first leads to an arrest in
prometaphase (Figure 2A) which is caused by activation of the
spindle assembly checkpoint, but subsequently cells die without
exiting from mitosis again. Cell death coincides with the cleav-
age of caspase substrates and fragmentation of DNA, indicating
that an apoptotic pathway is activated. Histological studies and
in vivo imaging experiments in mice carrying human tumor xeno-
grafts have shown that depletion of Plk1 by small hairpin RNAs or
by BI 2536 also causes a mitotic arrest, followed by a wave of
apoptosis in vivo (Spankuch-Schmitt et al., 2002; Steegmaier
et al., 2007).656 Developmental Cell 14, May 2008 ª2008 Elsevier Inc.Because Plk1 inhibition leads to activation of the spindle
assembly checkpoint, it is possible that Plk1 inhibitors kill cells
via a mechanism that is related to the cell death that is induced
by microtubule binding compounds, such as Vinka alkaloids
and Taxol. However, Nocodazole or Taxol can arrest cultured
tumor cells, such as HeLa cells, for many hours in mitosis with
relatively low loss of viability, whereas Plk1 inhibition kills cells
efficiently. It will therefore be interesting to determine if activation
of the spindle assembly checkpoint alone is responsible for the
activation of apoptosis following Plk1 inhibition. In cancer ther-
apy, Plk1 inhibitors could further differ from microtubule binding
compounds because microtubules have important functions in
postmitotic cells, whereas Plk1 expression is restricted to prolif-
erating cells (Hamanaka et al., 1994; Holtrich et al., 1994). Plk1
inhibitors may therefore not cause some of the side effects
that are seen in patients treated with Vinka alkaloids and Taxol.
However, it remains to be seen if Plk1 inhibitors will be able to
kill tumor cells at doses that can still be tolerated by normal
proliferating cells, e.g., in the bone marrow.
Outlook
This is undoubtedly an exciting time for Plk1 research in animal
cells. The availability of novel chemical tools to selectively inhibit
this enzyme has begun to fill in a lot of gaps in our understanding
of Plk1 functions during mitosis. We expect that these tools will
also prove invaluable for addressing the functions of Plk1 during
meiotic divisions. We might have only scratched the surface
regarding targets and molecular functions of this multifaceted
kinase that helps preparing cells for division and then carries
them right through to the end. Small-molecule Plk1 inhibitors
are not only fantastic research tools but also potential antimitotic
chemotherapeutic drugs that will hopefully soon prove beneficial
for patients suffering from cancer. Although small-molecule
compounds are ideally suited for the temporal dissection of
biological processes, delineating the functions of enzymes like
Plk1 at specific subcellular locations will necessitate different
approaches.
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